US 12084516
Anti-C5 antibody combinations and uses thereof
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 12084516 (Anti-C5 antibody combinations and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K2039/545, A61K31/573